Epigenetic modifications associated to diabetic peripheral neuropathic pain (Review) DOI Creative Commons
Tianle Gao,

Jingya Luo,

Jie Fan

и другие.

Molecular Medicine Reports, Год журнала: 2024, Номер 31(1)

Опубликована: Ноя. 13, 2024

The present review aimed to provide an update on the scientific progress of role epigenetic modifications diabetic peripheral neuropathic pain (DPNP). DPNP is a devastating and troublesome complication diabetes mellitus (DM), which affects one third patients with DM causes severe hyperalgesia allodynia, leading challenges in treatment these patients. pathophysiology multifactorial not yet fully understood options for this disease are currently unsatisfactory. underlying mechanisms have largely been explored animal models mechanism‑derived approach might offer potential therapeutic‑target attenuating certain phenotypes DPNP. Altered gene expression levels within or central nervous systems (CNS) crucial mechanism DPNP, however, transcriptional genes elucidated. Epigenetic modifications, such as DNA methylation histone (methylation, acetylation, phosphorylation), can alter via chromatin remodeling. Moreover, it has reported that altering CNS, contributes changes both sensitivity pharmacological efficacy Therefore, summarized findings relevant literature alterations therapeutic targeting future disease.

Язык: Английский

Understanding GEMIN5 Interactions: From Structural and Functional Insights to Selective Translation DOI Creative Commons
Encarnación Martı́nez-Salas, Salvador Abellan, Rosario Francisco‐Velilla

и другие.

Wiley Interdisciplinary Reviews - RNA, Год журнала: 2025, Номер 16(2)

Опубликована: Март 1, 2025

ABSTRACT GEMIN5 is a predominantly cytoplasmic protein, initially identified as member of the survival motor neurons (SMN) complex. In addition, this abundant protein modulates diverse aspects RNA‐dependent processes, executing its functions through formation multi‐component complexes. The modular organization structural domains present in enables to perform various interaction with distinct partners. responsible for recognition small nuclear (sn)RNAs N‐terminal region, and therefore snRNP assembly. Beyond role spliceosome assembly, regulates translation either RNAs or proteins. central robust dimerization domain acts hub protein–protein interaction, while non‐canonical RNA‐binding site located towards C‐terminus. Interestingly, partitioning mRNAs into polysomes, likely due capacity ability bind native ribosomes. Understanding functional has brought an increasing interest last years important implications human disease. Patients carrying biallelic variants suffer from neurodevelopmental delay, hypotonia, cerebellar ataxia. This review discusses recent relevant works aimed at understanding molecular mechanisms activity gene expression, also challenges discover new functions.

Язык: Английский

Процитировано

0

Ribosome profiling reveals that post-transcriptional control of Nalf1 by heterogeneous nuclear ribonucleoprotein L is required for paclitaxel-induced neuropathic pain DOI
June Bryan de la Peña, Guadalupe García, Zachary T. Campbell

и другие.

Pain, Год журнала: 2025, Номер unknown

Опубликована: Апрель 2, 2025

Abstract Sensory neurons are integral to the genesis and maintenance of neuropathic pain. The molecular mechanisms that mediate long-lived changes in their excitability unclear. Here, we leverage functional genomics approaches survey RNA abundance translation dorsal root ganglion from a mouse model paclitaxel-induced We focus specifically on females as paclitaxel is first-line therapy for breast cancer. sequencing data indicate substantially more occur at level (n = 404) than transcription decay 109). discovered core subunit sodium leak channel (NALCN) channel, auxiliary factor 1 (NALF1), preferentially translated response paclitaxel. This effect mediated by RNA-binding protein heterogeneous nuclear ribonucleoprotein L (HNRNP L). Heterogeneous binds 14 base CA-rich element (CARE) Nalf1 3′ untranslated region (3′UTR). Genetic elimination either HNRNP L, CARE motif, or pore-forming nonselective NALCN diminishes pain amplification vivo. Collectively, these results illustrate an situated 3′UTR required female mice.

Язык: Английский

Процитировано

0

The RNA-binding protein CELF4 is a negative regulator of sensory neuron excitability and mechanical and heat behavioral sensitivity DOI Creative Commons

Madison Mueth,

Peter Neufeld,

Merilla Michael

и другие.

Neurobiology of Pain, Год журнала: 2025, Номер unknown, С. 100184 - 100184

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0

The Functional Diversity of Chromatin‐Associated RNA Binding Proteins in Transcriptional and Post‐Transcriptional Regulation DOI
Min Zhou, Jun Yang, Chuan Huang

и другие.

Wiley Interdisciplinary Reviews - RNA, Год журнала: 2025, Номер 16(3)

Опубликована: Май 1, 2025

ABSTRACT RNA‐binding proteins (RBPs) are a diverse class of that interact with their target RNA molecules to regulate gene expression at the transcriptional and post‐transcriptional levels. RBPs contribute almost all aspects processing sequence‐specific, structure‐specific, nonspecific binding modes. Advances in our understanding mechanisms RBP‐mediated regulatory networks consisting DNAs, RNAs, protein complexes association between these human diseases have been made very recently. Here, we discuss “unconventional” functions regulation by focusing on cutting‐edge investigations chromatin‐associated (ChRBPs). We briefly introduce examples how ChRBPs influence genomic features molecular structures level transcription. In addition, focus various biogenesis, transportation, stability control, translation ability circular (circRNAs). Lastly, raise several questions about clinical significance potential therapeutic utility disease‐relevant RBPs.

Язык: Английский

Процитировано

0

Epigenetic modifications associated to diabetic peripheral neuropathic pain (Review) DOI Creative Commons
Tianle Gao,

Jingya Luo,

Jie Fan

и другие.

Molecular Medicine Reports, Год журнала: 2024, Номер 31(1)

Опубликована: Ноя. 13, 2024

The present review aimed to provide an update on the scientific progress of role epigenetic modifications diabetic peripheral neuropathic pain (DPNP). DPNP is a devastating and troublesome complication diabetes mellitus (DM), which affects one third patients with DM causes severe hyperalgesia allodynia, leading challenges in treatment these patients. pathophysiology multifactorial not yet fully understood options for this disease are currently unsatisfactory. underlying mechanisms have largely been explored animal models mechanism‑derived approach might offer potential therapeutic‑target attenuating certain phenotypes DPNP. Altered gene expression levels within or central nervous systems (CNS) crucial mechanism DPNP, however, transcriptional genes elucidated. Epigenetic modifications, such as DNA methylation histone (methylation, acetylation, phosphorylation), can alter via chromatin remodeling. Moreover, it has reported that altering CNS, contributes changes both sensitivity pharmacological efficacy Therefore, summarized findings relevant literature alterations therapeutic targeting future disease.

Язык: Английский

Процитировано

2